Health Equity Infrastructure for Rare Disease

Health Equity Infrastructure for Rare Disease describes itself simply: "Elevate Impact is where clinical trials begin: patient advocates, clinicians, researchers, and sponsors design rare-disease research together on one platform, starting with sickle cell." To AI engines like ChatGPT and Perplexity it is partially visible, scoring 5.5 out of 10, readable in places and missing in others.

On the page itself the strengths are clear: a clear heading structure, a clearly stated business identity, visible credibility markers and sitemaps and entity links AI can follow. It is passable on some structured data. What holds it back is the technical files AI engines look for, such as llms.txt or an open robots.txt.

Away from its own site, other sites link to it. There is some, but not much, sign that the domain is only lightly established. Beyond that, AI engines do not yet recognise it as a distinct business, there is no press coverage to draw on, nobody is discussing it where AI engines look and it does not come up on Reddit. Those are earned elsewhere on the web, not fixed on the site itself.

The business dates to 2022.